Division of Internal Medicine 2 (University Hospital Krems)

2023

Impact of Immune Checkpoint Inhibitors on Bone Turnover in Cancer Patients: in Vitro Studies and Clinical Correlate

Gassner, T., Chittilappilly, C., Pirich, T., Lind, J., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M., Podar, K. & Vallet, S., 10 Mar 2023, In: Memo - Magazine of European Medical Oncology. 16 , Abstracts OeGHO / AHOP, O16.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

2022

1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, In: Journal for ImmunoTherapy of Cancer. p. A1300-A1300

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material

Vladimer, G., Alt, I., Sehlke, R., Lobley, A., Baumgärtler, C., Stulic, M., Hackner, K., Dzurillova, L., Petru, E., Hadjari, L., Lafleur, J., Singer, J., Krall, N., Šufliarsky, J., Hefler, L., Fuereder, T., Taubert, C., Boudesco, C. & Payne, A., 01 Dec 2022, In: Immuno-Oncology and Technology. 16, p. 100128

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

Somlyay, M., Durinikova, E., Besnard, J., Barbeau, O., Le Coz, J., Senekowitsch, M., Ergüner, B., Hackner, K., Dzurillova, L., Petru, E., Lafleur, J., Singer, J., Füreder, T., Paveley, R., Joseph, J., Aswad, F., Winkler-Penz, T., Sehlke, R., Boudesco, C. & Vladimer, G., Oct 2022, In: European Journal of Cancer. 174, p. S44-S45

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

Die Auswirkung von Osteoblasten und deren Präkursoren auf das Schicksal von Brustkrebszellen

Lind, J., Gassner, T., Aksoy, O., Sunder-Plaßmann, V., Pecherstorfer, M., Podar, K. & Vallet, S., 27 Sept 2022, In: Oncology Research and Treatment. 45 | Meeting Reports/Abstracts, Suppl. 2, P360.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

2 Citations (Scopus)

Effects of immune checkpoint-inhibitors on bone turnover in cancer patients

Pirich, T., Hackner, K., Zwickl-Traxler, E., Gassner, T., Errhalt, P., Pecherstorfer, M., Podar, K. & Vallet, S., 08 Mar 2022, In: Memo - Magazine of European Medical Oncology. 15 | Abstracts OeGHO / AHOP, Supplement 3/22, O05.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

P-283: TRIATLON - triple class exposed/refractory multipLe myeloma patients: a real world analysis (RWA) from the Austrian Myeloma Registry (AMR)

Willenbacher, E., Pichler, P., Strassl, I., Krauth, M., Agis, H., Sormann, S., Hartmann, B., Podar, K., Weger, R. & Willenbacher, W., 01 Aug 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S193-S194

Research output: Journal article (peer-reviewed) › Conference contribution to journal

S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL)

Ludwig, H., Melchardt, T., Sormann, S., Zojer, N., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Schreder, M., Ruckser, R., Bozic, B., Krauth, M. T., Petzer, A., Schmitt, C., Machherndl-Spandl, S. & Agis, H. & 5 others, Fillitz, M., Pönisch, W., Knop, S., Paiva, B. & Greil, R., 2022, In: HemaSphere. 6, p. 80-81

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

2021

Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy – Update: OeGHO Frühjahrstagung, 8.-10.4.2021, Online

Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Memo - Magazine of European Medical Oncology. 14, Suppl. 2, p. 23-41 19 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria

Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S19-S20

Research output: Journal article (peer-reviewed) › Conference contribution to journal

P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria

Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S83-S84

Research output: Journal article (peer-reviewed) › Conference contribution to journal

2020

Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy: Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020: Abstracts

Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2020, In: Oncology Research and Treatment. 43, Suppl. 4, p. 92

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Open Access

Immunophenotyping of Baseline Bone Marrow Reveals a Specific Pattern of Immune Cells Associated with Greater Depth and Sustained Response in Newly Diagnosed Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Control (AGMT MM 02 Study)

Manrique, I., Greil, R., Andel, J., Sormann, S., Hartmann, B. L., Podar, K., Egle, A., Petzer, A., Zojer, N., Ruckser, R., Bozic, B., Schmitt, C. A., Machherndl-Spandl, S., Agis, H., Schreder, M., Krauth, M.-T., Tinchon, C., Fillitz, M., Melchardt, T. & Paiva, B. & 1 others, Ludwig, H., 2020, In: Blood. 136, Supplement 1, p. 29-30 2 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Quality of Life in Newly Diagnosed Patients with Multiple Myeloma Randomized to Either Krd or Ktd Induction Therapy Followed By Carfilzomib Maintenance or Control (AGMT MM 02 trial)

Ludwig, H., Melchardt, T., Andel, J., Gunsilius, E., Sormann, S., Hinke, A., Hartmann, B. L., Podar, K., Willenbacher, W., Egle, A., Petzer, A., Zojer, N., Wöll, E., Ruckser, R., Bozic, B., Schmitt, C. A., Machherndl-Spandl, S., Krauth, M.-T., Schreder, M. & Agis, H. & 3 others, Tinchon, C., Fillitz, M. & Greil, R., 2020, In: Blood. 136, Supplement 1, p. 27-29 3 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

2019

Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02): American Society of Hematology, 61th Annual Meeting, scientific session

Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B. L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Ruckser, R., Bozic, B., Krauth, M.-T., Petzer, A., Schmitt, C. A., Machherndl-Spandl, S., Agis, H., Paiva, B. & Greil, R., 2019, In: Blood. 134, Supplement_1, p. 696 1 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy: American Society of Hematology, 61th Annual Meeting, scientific session

Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Sattler, M., Bakiri, L., Wagner, E. F., Percherstorfer, M. & Podar, K., 2019, In: Blood. 134, Supplement_1, p. 4415 1 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group: American Society of Hematology, 61th Annual Meeting, scientific session

Pleyer, L., Pfeilstocker, M., Stauder, R., Heibl, S., Sill, H., Girschikofsky, M., Stampfl-Mattersberger, M., Tinchon, C., Petzer, A., Schmitt, C. A., Vallet, S., Mandac, I., Geissler, K., Sperr, W. R., Leisch, M., Egle, A., Melchardt, T., Fusinato, J., Piringer, G. & Zebisch, A. & 4 others, Machherndl-Spandl, S., Wolf, D., Keil, F. & Greil, R., 2019, In: Blood. 134, Supplement_1, p. 3821 1 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis: American Society of Hematology, 61th Annual Meeting, scientific session

Fan, F., Malvestiti, S., Shen, Y., Morelli, E., Mishima, Y., Seckinger, A., Hose, D., Bakiri, L., Vallet, S., Sattler, M., Roccaro, A. M., Goldschmidt, H., Percherstorfer, M., Sun, C., Hu, Y., Wagner, E. F., Tassone, P., Ghobrial, I. M., Jaeger, D. & Podar, K., 2019, In: Blood. 134, Supplement_1, p. 4341 1 p.

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Division of Internal Medicine 2 (University Hospital Krems)

Research output

Search results